Covid-19 rapidly test a novel therapeutic strategy for covid-19 in human organoids and blood vessel structures

Ended Project Grant Awarded Last action

Award ID
W81XWH2110006
Recipient
Awarding agency
Obligated
$2,239,507

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Seattle, WA 98195, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The University of Washington was awarded a $2.2 million project grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from January 2021 through January 2025 to rapidly test a novel therapeutic strategy for COVID-19 using human organoids and blood vessel structures.

Through this funding, the University of Washington will investigate medical solutions for COVID-19 using innovative organoid and blood vessel model systems. The research aims to transform healthcare by developing impactful treatments for the novel coronavirus. The project supports the Military Medical Research and Development program's goals of investigating medical solutions for the battlefield and transforming health care through innovative biomedical research.

Quick answers

Who received award W81XWH2110006?

W81XWH2110006 was awarded to University Of Washington by Medical Command (Department of the Army) on January 15, 2021.

How much is award W81XWH2110006 worth?

$2,239,507 has been obligated on W81XWH2110006.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login